Trial Profile
Phase II trial of VGX 100 in patients with recurrent glioblastoma multiforme.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; VGX 100 (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 24 Dec 2013 New trial record